Derksen J, Nagesser S K, Meinders A E, Haak H R, van de Velde C J
Department of General Internal Medicine, University Hospital, Leiden, The Netherlands.
N Engl J Med. 1994 Oct 13;331(15):968-73. doi: 10.1056/NEJM199410133311502.
Hirsutism in women is usually caused by benign adrenal or ovarian disorders, but it can also be caused by adrenal carcinoma. The most effective way to identify such carcinomas is not known.
We measured serum and urinary steroids before and after the administration of 3 mg of dexamethasone per day for five days in 14 hirsute women with histologically proved adrenal tumors (12 adrenal carcinomas and 2 adrenal adenomas) and in 73 women with hirsutism of non-neoplastic origin.
All the women with adrenal tumors had elevated basal serum concentrations of testosterone or dehydroepiandrosterone sulfate, as compared with 36 of the 73 women with non-neoplastic hirsutism (sensitivity, 100 percent; 95 percent confidence interval, 77 to 100; specificity, 50 percent; 95 percent confidence interval, 38 to 62). After the administration of dexamethasone, serum dehydroepiandrosterone sulfate concentrations and urinary 17-ketosteroid excretion decreased to values similar to those in normal women in all the women with non-neoplastic hirsutism, but in none of the 12 with adrenal tumors who were tested. All the women who did not have adrenal tumors had serum cortisol concentrations below 3.3 micrograms per deciliter (90 nmol per liter) after dexamethasone administration, whereas in all 12 patients tested who had tumors the values were higher. The suppression of serum dehydroepiandrosterone sulfate and cortisol and urinary 17-ketosteroid excretion excluded the likelihood of adrenal tumors with a sensitivity of 100 percent (95 percent confidence interval, 74 to 100) and a specificity of 100 percent (95 percent confidence interval, 89 to 100).
Among women with hirsutism, an adrenal tumor is unlikely if the patient has normal basal serum concentrations of testosterone and dehydroepiandrosterone sulfate. In women in whom these concentrations are elevated, a tumor is unlikely if the serum concentration of dehydroepiandrosterone sulfate and urinary 17-ketosteroid excretion are in the normal basal range and the serum cortisol concentration is less than 3.3 micrograms per deciliter after the administration of dexamethasone.
女性多毛症通常由良性肾上腺或卵巢疾病引起,但也可能由肾上腺癌导致。目前尚不清楚识别此类癌症的最有效方法。
我们对14名经组织学证实患有肾上腺肿瘤(12例肾上腺癌和2例肾上腺腺瘤)的多毛女性以及73例非肿瘤性多毛症女性,在每天服用3毫克地塞米松,持续五天前后,测量了血清和尿类固醇。
与73例非肿瘤性多毛症女性中的36例相比,所有患有肾上腺肿瘤的女性基础血清睾酮或硫酸脱氢表雄酮浓度均升高(敏感性为100%;95%置信区间为77%至100%;特异性为50%;95%置信区间为38%至62%)。服用地塞米松后,所有非肿瘤性多毛症女性的血清硫酸脱氢表雄酮浓度和尿17 - 酮类固醇排泄量降至与正常女性相似的值,但在接受测试的12例肾上腺肿瘤患者中均未出现这种情况。所有无肾上腺肿瘤的女性在服用地塞米松后血清皮质醇浓度低于3.3微克/分升(90纳摩尔/升),而在所有接受测试的12例肿瘤患者中,该值均较高。血清硫酸脱氢表雄酮、皮质醇以及尿17 - 酮类固醇排泄量的抑制排除了肾上腺肿瘤的可能性,敏感性为100%(95%置信区间为74%至100%),特异性为100%(95%置信区间为89%至100%)。
在多毛症女性中,如果患者基础血清睾酮和硫酸脱氢表雄酮浓度正常,则不太可能患有肾上腺肿瘤。在这些浓度升高的女性中,如果硫酸脱氢表雄酮血清浓度和尿17 - 酮类固醇排泄量处于正常基础范围,且服用地塞米松后血清皮质醇浓度低于3.3微克/分升,则不太可能患有肿瘤。